Abstract

Establishing a Structured Pharmacy Training Program in Sterile Compounding

Author(s): Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq

Issue: Nov/Dec 2020 - Volume 24, Number 6

Page(s): 460-465

Download in electronic PDF format for $75

Abstract

The objective of this study was to describe a structured pharmacy training program in sterile compounding in a comprehensive cancer center in Jordan. A previously performed gap analysis showed a degree of non-compliance with the international standards in certain elements of sterile compounding. A structured training program with theoretical and practical domains was developed and implemented. The trainees were required to complete a compounding competency assessment at the end of the training. A questionnaire was distributed to evaluate the trainees’ satisfaction. At one year of implementation, 25 pharmacists and 7 pharmacy technicians were enrolled into the training program. A questionnaire was conducted on 26 trainees. Based on the questionnaire results, 100% of the trainees were satisfied regarding the training objectives and the instructors' performance; 11.5% of the trainees stated that more time is needed for each trainee; and 3.8% said that more time is needed for the discussion. The development and implementation of a pharmaceutical sterile compounding training program in a comprehensive cancer care center was achieved by incorporating theoretical and practical techniques, with documented competency of trainees who reported satisfaction with the program. The optimal time dedicated for this program should be evaluated in future studies.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2020 Pg. 92	PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 460-465	Establishing a Structured Pharmacy Training Program in Sterile Compounding Author(s): Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
Nov/Dec 2021 Pg. 491-496	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 180	PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2 Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 115-124	Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice Author(s): Kelley Brian
Sep/Oct 2007 Pg. 404-410	Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2007 Pg. 302-305	Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Okeke Claudia C
Sep/Oct 2008 Pg. 440-443	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2008 Pg. 136-144	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2013 Pg. 283-288	United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Author(s): Newton David W
May/Jun 2008 Pg. 252-257	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2012 Pg. 6-10	Misinterpretation of United States Pharmacopeia Chapter <797> Author(s): McElhiney Linda F
Jan/Feb 2012 Pg. 64-68	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4 Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 146-150	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 322-329	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Author(s): Okeke Claudia C, Allen Loyd V Jr
May/Jun 2017 Pg. 180	PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 234-238	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2011 Pg. 328-331	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 314-323	Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2006 Pg. 36-39	Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations Author(s): Dawson Michael F